July 1, 2020Journal for ImmunoTherapy of Cancer64 citationsOpen Access

Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model

SLSai Ping LauErasmus MC NMNadine van MontfoortLeiden University Medical Center PKPriscilla KindermanLeiden University Medical Center

Key Points

Key points are not available for this paper at this time.

Abstract

These results demonstrate the potency of DC therapy in combination with CD40-stimulation for the treatment of pancreatic cancer and provide directions for near future clinical trials.

AIに質問

Bookmark

View Full Paper